Jenny Taylor (scientist)

Last updated

Jenny Taylor
Born
Jenny Carmeron Taylor
Alma mater University of Oxford (BA, DPhil)
Scientific career
Fields Translational genomics
Institutions Weatherall Institute of Molecular Medicine
University of Oxford
Thesis Molecular interactions of P-glycoprotein  (1997)
Website www.well.ox.ac.uk/people/jenny-taylor OOjs UI icon edit-ltr-progressive.svg

Jenny Carmeron Taylor is a British geneticist who is Professor of Genomic Medicine at the University of Oxford. Taylor is the Director of the Oxford Biomedical Research Centre Genetics Theme. Her research considers whole genome sequencing and ways to integrate genetic research into the National Health Service.

Contents

Early life and education

Taylor was an undergraduate student at the St Edmund Hall, Oxford. [1] [2] She remained in Oxford for her doctoral research, joining the Weatherall Institute of Molecular Medicine. [3] [1]

Research and career

After graduating she joined a start-up company focusing on the genetics of diseases. [1] In 2002, Taylor moved to the Oxford Genetics Knowledge Park. [1] She was Director of the Oxford Biomedical Research Centre Genetics Theme, which is supported by the Department of Health and Social Care. [4] In this capacity, she oversees partnerships between researchers working in genetics and physicians in the National Health Service. In particular, she has developed novel ways to perform DNA sequencing. She hopes that these capabilities will be deployed across the health service, allowing for monitoring of the subtle changes in DNA that take place in various medical conditions. [5] She worked in collaboration with Illumina to show that in whole genome sequencing could be used to diagnose patients with genetic disorders with a greater sensitivity than conventional genetic testing. [6] These technologies – which can check 20,000 genes at the same as opposed to checking individual genes sequentially – offer hope for patients with rare diseases. [6] Accurate diagnoses can enable physicians to select the correct medication or to set up the appropriate levels of support for people with learning disabilities. [6] In 2013, she was elected a Fellow by special election at the University of Oxford.

Publications

Her publications [7] [8] include:

Related Research Articles

<span class="mw-page-title-main">Genetics</span> Science of genes, heredity, and variation in living organisms

Genetics is the study of genes, genetic variation, and heredity in organisms. It is an important branch in biology because heredity is vital to organisms' evolution. Gregor Mendel, a Moravian Augustinian friar working in the 19th century in Brno, was the first to study genetics scientifically. Mendel studied "trait inheritance", patterns in the way traits are handed down from parents to offspring over time. He observed that organisms inherit traits by way of discrete "units of inheritance". This term, still used today, is a somewhat ambiguous definition of what is referred to as a gene.

<span class="mw-page-title-main">Germline mutation</span> Inherited genetic variation

A germline mutation, or germinal mutation, is any detectable variation within germ cells. Mutations in these cells are the only mutations that can be passed on to offspring, when either a mutated sperm or oocyte come together to form a zygote. After this fertilization event occurs, germ cells divide rapidly to produce all of the cells in the body, causing this mutation to be present in every somatic and germline cell in the offspring; this is also known as a constitutional mutation. Germline mutation is distinct from somatic mutation.

<span class="mw-page-title-main">Walter Bodmer</span> German-born British human geneticist

Sir Walter Fred Bodmer is a German-born British human geneticist.

<span class="mw-page-title-main">MUTYH</span> Protein-coding gene in the species Homo sapiens

MUTYH is a human gene that encodes a DNA glycosylase, MUTYH glycosylase. It is involved in oxidative DNA damage repair and is part of the base excision repair pathway. The enzyme excises adenine bases from the DNA backbone at sites where adenine is inappropriately paired with guanine, cytosine, or 8-oxo-7,8-dihydroguanine, a common form of oxidative DNA damage.

<span class="mw-page-title-main">POLD1</span> Protein-coding gene in the species Homo sapiens

The gene polymerase delta 1 (POLD1) encodes the large, POLD1/p125, catalytic subunit of the DNA polymerase delta (Polδ) complex. The Polδ enzyme is responsible for synthesizing the lagging strand of DNA, and has also been implicated in some activities at the leading strand. The POLD1/p125 subunit encodes both DNA polymerizing and exonuclease domains, which provide the protein an important second function in proofreading to ensure replication accuracy during DNA synthesis, and in a number of types of replication-linked DNA repair following DNA damage.

<span class="mw-page-title-main">BAP1</span> Protein-coding gene in the species Homo sapiens

BRCA1 associated protein-1 is a deubiquitinating enzyme that in humans is encoded by the BAP1 gene. BAP1 encodes an 80.4 kDa nuclear-localizing protein with a ubiquitin carboxy-terminal hydrolase (UCH) domain that gives BAP1 its deubiquitinase activity. Recent studies have shown that BAP1 and its fruit fly homolog, Calypso, are members of the polycomb-group proteins (PcG) of highly conserved transcriptional repressors required for long-term silencing of genes that regulate cell fate determination, stem cell pluripotency, and other developmental processes.

The exome is composed of all of the exons within the genome, the sequences which, when transcribed, remain within the mature RNA after introns are removed by RNA splicing. This includes untranslated regions of messenger RNA (mRNA), and coding regions. Exome sequencing has proven to be an efficient method of determining the genetic basis of more than two dozen Mendelian or single gene disorders.

<span class="mw-page-title-main">Exome sequencing</span> Sequencing of all the exons of a genome

Exome sequencing, also known as whole exome sequencing (WES), is a genomic technique for sequencing all of the protein-coding regions of genes in a genome. It consists of two steps: the first step is to select only the subset of DNA that encodes proteins. These regions are known as exons—humans have about 180,000 exons, constituting about 1% of the human genome, or approximately 30 million base pairs. The second step is to sequence the exonic DNA using any high-throughput DNA sequencing technology.

<span class="mw-page-title-main">Wellcome Centre for Human Genetics</span> Research Institute at the University of Oxford

The Wellcome Centre for Human Genetics is a human genetics research centre of the Nuffield Department of Medicine in the Medical Sciences Division, University of Oxford, funded by the Wellcome Trust among others.

B K Thelma commonly known as Bittianda Kuttapa Thelma is a professor in the Department of Genetics at the University of Delhi, South Campus, New Delhi, India. She is the Principal investigator and Co-ordinator of the Centre of excellence on Genomes Sciences and Predictive Medicine funded by the Govt. of India. She is also the Co-ordinator of a major project on newborn screening for inborn errors of metabolism in Delhi state which aims to demonstrate the feasibility of mandatory screening of newborns in the country and to generate epidemiological data for the testable IEMs in the genetically distinct Indian population, for the first time.

A rare variant is a genetic variant which occurs at low frequency in a population. Rare variants play a significant role in both complex and Mendelian disease and are responsible for a portion of the missing heritability of complex diseases. The theoretical case for a significant role of rare variants is that alleles that strongly predispose an individual to disease will be kept at low frequencies in populations by purifying selection. Rare variants are increasingly being studied, as a consequence of whole exome and whole genome sequencing efforts. While these variants are individually infrequent in populations, there are many in human populations, and they can be unique to specific populations. They are more likely to be deleterious than common variants, as a result of rapid population growth and weak purifying selection. They have been suspected of acting independently or along with common variants to cause disease states.

Eleftheria Zeggini is a director of the institute of translational genomics in Helmholtz Zentrum München and a professor at the Technical University of Munich (TUM). Previously she served as a research group leader at the Wellcome Trust Sanger Institute from 2008 to 2018 and an honorary professor in the department of health sciences at the University of Leicester in the UK.

Rosalind Anne Eeles is a Professor of Oncogenetics at the Institute of Cancer Research and clinician at the Royal Marsden NHS Foundation Trust. She is a leader in the field of genetic susceptibility to prostate cancer, and is known for the discovery of 14 genetic variants involved in prostate cancer predisposition. According to ResearchGate, Eeles has published more than 500 articles in peer-reviewed journals, with over 34,000 citations and an h-index of 92. Eeles was elected a Fellow of the Academy of Medical Science in 2012. She was awarded a National Institute for Health Research Senior Investigator Emeritus in 2014.

Matthew Edward Hurles is director of the Wellcome Sanger Institute and an honorary professor of Human Genetics and Genomics at the University of Cambridge.

Ian Tomlinson is a director of the Institute of Cancer and Genomic Sciences at the University of Birmingham.

<span class="mw-page-title-main">Tara Matise</span> American geneticist

Tara Matise is an American geneticist at Rutgers University. Since 2018, she has served as chair of the Department of Genetics. Her research interests span computational genetics, data science, and human genetics. She is co-director of the Rutgers University Genetics Coordinating Center.

Krina Tynke Zondervan is a Dutch biomedical scientist who is a Professor of Genomic Epidemiology at the University of Oxford. She serves on the board of the World Endometriosis Society.

<span class="mw-page-title-main">Deborah Nickerson</span> American human genomics researcher (1954–2021)

Deborah Ann "Debbie" Nickerson was an American human genomics researcher. She was professor of genome sciences at the University of Washington. Nickerson founded and directed of one of the five clinical sites of the Gregor Consortium and was a major contributor to many genomics projects, including the Human Genome Project and the International HapMap Project.

<span class="mw-page-title-main">Susanna-Assunta Sansone</span> British-Italian data scientist

Susanna-Assunta Sansone is a British-Italian data scientist who is professor of data readiness at the University of Oxford where she leads the data readiness group and serves as associate director of the Oxford e-Research Centre. Her research investigates techniques for improving the interoperability, reproducibility and integrity of data.

Anne Goriely is a British geneticist who is a professor of human genetics at the University of Oxford. Her research investigates the molecular mechanisms that underpin genetic variation, particularly mutations in the male germline.

References

  1. 1 2 3 4 "Jenny Taylor, Fellow by Special Election in Human Genetics". seh.ox.ac.uk. St Edmund Hall, Oxford. Retrieved 7 April 2022.
  2. "Women Inspire: An Introduction to the Exhibition" (PDF). seh.ox.ac.uk.
  3. Taylor, Jenny Carmeron (1997). Molecular interactions of P-glycoprotein. ox.ac.uk (DPhil thesis). University of Oxford. OCLC   53668171. EThOS   uk.bl.ethos.363732.
  4. "Jenny Taylor". well.ox.ac.uk. Retrieved 7 April 2022.
  5. "Professor Jenny Taylor". ox.ac.uk. University of Oxford. Retrieved 7 April 2022.
  6. 1 2 3 University, Oxford. "Project brings whole genome sequencing into the clinic". medicalxpress.com. Retrieved 7 April 2022.
  7. Jenny Taylor publications indexed by the Scopus bibliographic database. (subscription required)
  8. Jenny Taylor publications from Europe PubMed Central
  9. Dixon AL; Liang L; Moffatt MF; et al. (October 2007). "A genome-wide association study of global gene expression". Nature Genetics . 39 (10): 1202–7. doi:10.1038/NG2109. ISSN   1061-4036. PMID   17873877. Wikidata   Q29614592.
  10. Claire Palles; Jean-Baptiste Cazier; Kimberley M Howarth; et al. (February 2013). "Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas". Nature Genetics . 45 (2): 136–44. doi:10.1038/NG.2503. ISSN   1061-4036. PMC   3785128 . PMID   23263490. Wikidata   Q24617520. (erratum)
  11. Roddy Walsh; Kate Thomson; James Ware; et al. (17 August 2016). "Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples". Genetics in Medicine . 19 (2): 192–203. doi:10.1038/GIM.2016.90. ISSN   1098-3600. PMC   5116235 . PMID   27532257. Wikidata   Q37424109.